MX9200725A - Tratamiento de cancer esofagico. tratamiento de cancer esofagico. - Google Patents

Tratamiento de cancer esofagico. tratamiento de cancer esofagico.

Info

Publication number
MX9200725A
MX9200725A MX9200725A MX9200725A MX9200725A MX 9200725 A MX9200725 A MX 9200725A MX 9200725 A MX9200725 A MX 9200725A MX 9200725 A MX9200725 A MX 9200725A MX 9200725 A MX9200725 A MX 9200725A
Authority
MX
Mexico
Prior art keywords
cancer treatment
esophageal cancer
esophageal
treatment
cancer
Prior art date
Application number
MX9200725A
Other languages
English (en)
Inventor
Randall Keith Johnson Johnson
Original Assignee
Smithkline Beecham Corp Smithk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp Smithk filed Critical Smithkline Beecham Corp Smithk
Publication of MX9200725A publication Critical patent/MX9200725A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9200725A 1991-02-21 1992-02-21 Tratamiento de cancer esofagico. tratamiento de cancer esofagico. MX9200725A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65893691A 1991-02-21 1991-02-21

Publications (1)

Publication Number Publication Date
MX9200725A true MX9200725A (es) 1992-09-01

Family

ID=24643326

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200725A MX9200725A (es) 1991-02-21 1992-02-21 Tratamiento de cancer esofagico. tratamiento de cancer esofagico.

Country Status (8)

Country Link
EP (1) EP0572563A4 (es)
JP (1) JPH06505487A (es)
KR (1) KR930702985A (es)
AU (1) AU664172B2 (es)
CA (1) CA2104449A1 (es)
MX (1) MX9200725A (es)
PT (1) PT100154A (es)
WO (1) WO1992014470A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395541B1 (en) 1996-05-23 2002-05-28 The Rockefeller University Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
WO2001066144A2 (en) * 2000-03-08 2001-09-13 Rhode Island Hospital, A Lifespan Partner Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity
ATE469242T1 (de) 2000-03-27 2010-06-15 Univ Jefferson Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
EP1907582B1 (en) 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
ES2371171B1 (es) * 2010-06-08 2012-11-16 Consejo Superior De Investigaciones Científicas (Csic) Derivados de camptotecina como agentes antitumorales.
CN102659800B (zh) * 2012-05-11 2014-09-03 中国药科大学 一类低氧激活抗肿瘤化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells

Also Published As

Publication number Publication date
KR930702985A (ko) 1993-11-29
AU664172B2 (en) 1995-11-09
AU1540692A (en) 1992-09-15
EP0572563A4 (en) 1993-12-29
JPH06505487A (ja) 1994-06-23
CA2104449A1 (en) 1992-08-22
WO1992014470A1 (en) 1992-09-03
PT100154A (pt) 1993-05-31
EP0572563A1 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
DE59102292D1 (de) Katheter.
DE69203428D1 (de) Verbinder.
MX9202978A (es) Compuestos de amino-4-aril-tiazoles.
DE59203645D1 (de) Backofen.
FI920152A0 (fi) Kirurgisk borrschablon.
NO911429L (no) Stoffbehandling.
DE69203171T2 (de) Verbinder.
NO912158D0 (no) Behandling av undergrunnsformasjon.
DE69200956D1 (de) Panzerung.
DE69112449T2 (de) Endoskop.
FR2680419B1 (fr) Endoscopes.
MX9202702A (es) Proceso de bioblanqueo.
MX9200725A (es) Tratamiento de cancer esofagico. tratamiento de cancer esofagico.
NO911430D0 (no) Stoffbehandlingsmetode.
ES1016723Y (es) Boligrafo-pulverizador mejorado.
DE69101652D1 (de) Behandlungsofen.
FI923486A0 (fi) Terapeutiska aemnen.
FI923862A0 (fi) Anordning foer reducerad effektmatning.
DE69203364D1 (de) Verbinder.
DE69114853D1 (de) Abwasserbehandlung.
DE69106733T2 (de) Fleischbehandlung.
FI920701A0 (fi) Anordning foer terapeutisk tryck- behandling.
FI910753A (fi) Terapeutiska nukleocider.
DE69201785D1 (de) Verbinder.
FI923528A (fi) Terapeutiska aemnen.